ETA receptor blockade induces tubular cell proliferation and cyst growth in rats with polycystic kidney disease

Journal of the American Society of Nephrology

Volumn 14, Issue 2, 2003, Pages 367-376

  Hocher, Berthold ^a   Kalk, Philipp ^a   Slowinski, Torsten ^a   Godes, Michael ^a   Mach, Alexander ^a   Herzfeld, Sophia ^a   Wiesner, Doreen ^a   Arck, Petra Clara ^a   Neumayer, Hans H ^a   Nafz, Benno ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DARUSENTAN; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; LU 224332; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; KIDNEY BLOOD FLOW; KIDNEY CYST; KIDNEY POLYCYSTIC DISEASE; KIDNEY TUBULE CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION;

EID: 0037305126     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000042165.63601.65     Document Type: Article

References (34)

1. Qian Q, Harris PC, Torres VE; Treatment prospects for autosomal-dominant polycystic kidney disease. Kidney Int 59: 2005-2022, 2001
2. Amaout MA: Molecular genetics and pathogenesis of autosomal dominant polycystic kidney disease. Annu Rev Med 52: 93-123, 2001
3. Ecder T, Schrier RW: Hypertension in autosomal-dominant polycystic kidney disease: Early occurrence and unique aspects. J Am Soc Nephrol 12: 194-200, 2001
4. Peters DJ, Breuning M: Autosomal dominant polycystic kidney disease: Modification of disease progression. Lancet 358: 1439-1444, 2001
5. Gretz N, Ceccherini I, Kranzlin B, Kloting I, Devoto M, Rohmeiss P, Hocher B, Waldherr R, Romeo G: Gender-dependent disease severity in autosomal polycystic kidney disease of rats. Kidney Int. 48: 496-500, 1995
6. Giusti R, Neri M, Angelini D, Carlini A, Fiorini I, Bigongiari P, Antonelli A: Plasma concentration of endothelin and arterial pressure in patients with ADPKD. Contrib Nephrol 115: 118-121, 1995
7. Hocher B, Zart R, Schwarz A, Vogt V, Braun C, Thone-Reineke C, Braun N, Neumayer HH, Koppenhagen K, Bauer C, Rohmeiss P: Renal endothelin system in polycystic kidney disease. J Am Soc Nephrol 9: 1169-1177, 1998
8. Munemura C, Uemasu J, Kawasaki H: Epidermal growth factor and endothelin in cyst fluid from autosomal dominant polycystic kidney disease cases: Possible evidence of heterogeneity in cystogenesis. Am J Kidney Dis 24: 561-568, 1994
9. Nakamura T, Ebihara I, Fukui M, Osada S, Tomino Y, Masaki T, Goto K, Furuichi Y, Koide H: Increased endothelin and endothelin receptor mRNA expression in polycystic kidneys of cpk mice. J Am Soc Nephrol 4: 1064-1072, 1993
10. Hocher B, Thone-Reineke C, Rohmeiss P, Schmager F, Slowinski T, Burst V, Siegmund F, Quertermous T, Bauer C, Neumayer HH, Schleuning WD, Theuring F: Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension. J Clin Invest 99: 1380-1389, 1997
11. Grantham JJ: The etiology, pathogenesis, and treatment of autosomal dominant polycystic kidney disease: Recent advances. Am J Kidney Dis 28: 788-803, 1996
12. Nagao S, Ushijima T, Kasahara M, Yamaguchi T, Kusaka M, Matsuda J, Nagao M, Takahashi H: Closely linked polymorphic markers for determining the autosomal dominant allele (Cy) in rat polycystic kidney disease. Biochem Genet 37: 227-235, 1999
13. Hocher B, Schwarz A, Reinbacher D, Jacobi J, Lun A, Priem F, Bauer C, Neumayer HH, Raschack M: Effects of endothelin receptor antagonists on the progression of diabetic nephropathy. Nephron 87: 161-169, 2001
14. Nafz B, Berger K, Rosler C, Persson PB: Kinins modulate the sodium-dependent autoregulation of renal medullary blood flow, Cardiovasc Res 40: 573-579, 1998
15. Hocher B, George I, Diekmann F, Zart R, Rebstock J, Schwarz A, Thone-Reineke C, Neumayer HH, Bauer C: ETA receptor blockade induces fibrosis of the clipped kidney in two-kidney-one-clip renovascular hypertensive rats. J Hypertens 18: 1807-1814, 2000
16. Hocher B, Dembowski C, Slowinski T, Friese ST, Schwarz A, Siren AL, Neumayer HH, Thone-Reineke C, Bauer C, Nafz B, Ehrenreich. Impaired sodium excretion, decreased glomerular filtration rate and elevated blood pressure in endothelin receptor type B deficient rats. J Mol Med 78: 633-641, 2001
17. Arck PC, Handjiski B, Hagen E, Joachim R, Klapp BF, Paus R: Indications for a 'brain-hair follicle axis (BHA)': Inhibition of keratinocyte proliferation and up-regulation of keratinocyte apoptosis in telogen hair follicles by stress and substance P. FASEB J 15: 2536-2538, 2001
18. Wang D, Strandgaard S: The pathogenesis of hypertension in autosomal dominant polycystic kidney disease. J Hypertens 15: 925-933, 1997
19. Yoshida T, Kuwahara M, Maita K, Harada T: Immunohistochemical study on hypoxia in spontaneous polycystic liver and kidney disease in rats. Exp Toxicol Pathol 53: 123-128, 2001
20. Kakinuma Y, Miyauchi T, Yuki K, Murakoshi N, Goto K, Yamaguchi I: Novel molecular mechanism of increased myocardial endothelin-1 expression in the failing heart involving the transcriptional factor hypoxia-inducible factor-1alpha induced for impaired myocardial energy metabolism. Circulation 103: 2387-2394, 2001
21. Schiffrin EL: Role of endothelin-1 in hypertension and vascular disease. Am J Hypertens 14: 83S-89S, 2001
22. Braun C, Conzelmann T, Vetter S, Schaub M, Back WE, Yard B, Kirchengast M, Tullius SG, Schnulle P, van der Woude FJ, Rohmeiss. Prevention of chronic renal allograft rejection in rats with an oral endothelin A receptor antagonist. Transplantation 68: 739-746, 1999
23. Orth SR, Odoni G, Amann K, Strzelczyk P, Raschack M, Ritz E: The ET(A) receptor blocker LU 135252 prevents chronic transplant nephropathy in the "Fisher to Lewis" model. J Am Soc Nephrol 10: 387-391, 1999
24. Brochu E, Lacasse S, Moreau C, Lebel M, Kingma I, Grose JH, Lariviere R: Endothelin ET(A) receptor blockade prevents the progression of renal failure and hypertension in uraemic rats. Nephrol Dial Transplant 14: 1881-1888, 1999
25. Nelson JB, Hedican SP, George DJ, Reddi AH, Piantadosi S, Eisenberger MA, Simons JW: Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate. Nat Med 1: 944-949, 1995
26. Hocher B, Rohmeiss P, Diekmann F, Zart R, Vogt V, Schiller S, Bauer C, Koppenhagen K, Distler A, Gretz N: Distribution of endothelin receptor subtypes in the rat kidney. Renal and haemodynamic effects of the mixed (A/B) endothelin receptor antagonist bosentan. Eur J Clin Chem Clin Biochem 33: 463-472, 1995
27. Dean R, Zhuo J, Alcorn D, Casley D, Mendelsohn FA: Cellular localization of endothelin receptor subtypes in the rat kidney following in vitro labeling. Clin Exp Pharmacol Physiol 23: 524-531, 1996
28. Ramasubbu K, Gretz N, Bachmann S: Increased epithelial cell proliferation and abnormal extracellular matrix in rat polycystic kidney disease. J Am Soc Nephrol 9: 937-945, 1998
29. Murcia NS, Sweeney WE Jr, Avner ED: New insights into the molecular pathophysiology of polycystic kidney disease. Kidney Int 55: 1187-1197, 1999
30. Raschack M, Gock S, Unger L, Hahn A, Amberg W, Jansen R, Alken P, Weber A, Hergenroder S: LU 302 872 and its racemate (LU 224 332) show balanced endothelin-A/B receptor affinity, high oral activity, and inhibit human prostate tissue contractions. J Cardiovasc Pharmacol. 31: S241-S24, 1998
31. Shindo T, Kurihara H, Maemura K, Kurihara Y, Ueda O, Suzuki H, Kuwaki T, Ju KH, Wang Y, Ebihara A, Nishimatsu H, Moriyama N, Fukuda M, Akimoto Y, Hirano H, Morita H, Kumada M, Yazaki Y, Nagai R, Kimura K: Renal damage and salt-dependent hypertension in aged transgenic mice overexpressing endothelin-1. J Mol Med 80: 105-116, 2002
32. Sullivan LP, Wallace DP, Grantham JJ: Epithelial transport in polycystic kidney disease. Physiol Rev 78: 1165-1191, 1998
33. Meyrier A, Hill GS, Simon P: Ischemic renal diseases: New insights into old entities. Kidney Int. 54: 2-13, 1998
34. Gariepy CE, Ohuchi T, Williams SC, Richardson JA, Yanagisawa M: Salt-sensitive hypertension in endothelin-B receptor-deficient rats. J Clin Invest 105: 925-933, 2000